Argus Investors Counsel’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,382
Closed -$2.3M 119
2025
Q1
$2.3M Buy
4,382
+2,974
+211% +$1.52M 1.75% 18
2024
Q4
$712K Sell
1,408
-56
-4% -$31.8K 0.48% 69
2024
Q3
$856K Sell
1,464
-88
-6% -$49.8K 0.56% 66
2024
Q2
$790K Sell
1,552
-218
-12% -$107K 0.49% 71
2024
Q1
$876K Buy
1,770
+108
+6% +$54.9K 0.54% 71
2023
Q4
$875K Buy
1,662
+47
+3% +$25.1K 0.56% 68
2023
Q3
$814K Sell
1,615
-44
-3% -$21.7K 0.59% 68
2023
Q2
$798K Sell
1,659
-11
-0.7% -$5.38K 0.55% 69
2023
Q1
$789K Sell
1,670
-34
-2% -$16.4K 0.6% 67
2022
Q4
$904K Sell
1,704
-75
-4% -$39.7K 0.73% 62
2022
Q3
$899K Buy
1,779
+191
+12% +$100K 0.8% 61
2022
Q2
$816K Buy
1,588
+205
+15% +$103K 0.6% 65
2022
Q1
$705K Buy
1,383
+122
+10% +$58.8K 0.45% 69
2021
Q4
$633K Buy
1,261
+133
+12% +$60.2K 0.38% 72
2021
Q3
$441K Buy
1,128
+242
+27% +$100K 0.29% 77
2021
Q2
$355K Buy
+886
New +$353K 0.14% 79

Other funds holding UNH

Argus Investors Counsel's UNH Position: Q2 2025 in Review

Argus Investors Counsel sold out of UnitedHealth (UNH) in Q2 2025, closing a stake of 4,382 shares — an estimated $2.3M sold.

Argus Investors Counsel first reported a position in UNH in Q2 2021 and held it in 16 quarters. The position peaked at $2.3M in Q1 2025. 3,177 funds tracked by Wall St. Rank hold UNH as of Q2 2025.

  • Argus Investors Counsel reported no remaining UnitedHealth position as of Q2 2025 after selling out during the quarter.
  • Argus Investors Counsel sold 4,382 UnitedHealth shares in Q2 2025, an estimated $2.3M.
  • Argus Investors Counsel first reported a position in UnitedHealth in Q2 2021 and held it in 16 quarters.
  • Argus Investors Counsel's UnitedHealth position peaked at $2.3M in Q1 2025.
  • 3,177 funds tracked by Wall St. Rank held UnitedHealth as of Q2 2025.

Based on Argus Investors Counsel's 13F filing for Q2 2025, filed 17 Jul 2025.